cyclopentane has been researched along with Atherosclerosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batthyány, C; Dapueto, R; Escande, C; Galliussi, G; Kamaid, A; López, GV; Malacrida, L; Rodriguez-Duarte, J; Rossello, J; Schopfer, FJ | 1 |
| Amann, K; Arterburn, JB; Barton, M; Daniel, C; Fredette, NC; Howard, TA; Hu, C; Meyer, MR; Prossnitz, ER; Ramesh, C | 1 |
| Bergman, Y; Berkowitz, DE; Hori, D; Kim, JH; Pandey, D; Romer, LH | 1 |
| Bot, I; de Lange, EC; de Vries, H; de Witte, WE; Heitman, LH; IJzerman, AP; Kröner, MJ; Kuiper, J; Ortiz Zacarías, NV; Stamos, D; van der Berg, DJ; van der Velden, D; van Santbrink, PJ | 1 |
| Aviram, M; Fuhrman, B; Gantman, A; Hayek, T | 1 |
| Cho, BJ; Cho, HJ; Choi, SH; Jang, HC; Kang, SM; Kim, HS; Kim, M; Kim, YB; Lim, S; Park, HS; Park, KS; Shin, H; Yoon, JW | 1 |
| Abdalla, DS; Baldissera, LP; Bock, PM; Cruz, LA; Curi, R; Gutierrez, LL; Heck, TG; Homem de Bittencourt, PI; Janner, DR; Krause, MS; Lagranha, CJ; Lagranha, DJ; Lima, T; Maslinkiewicz, A; Peralta, JS; Scola, G; Senna, SM; Tavares, AM | 1 |
| Curi, R; de Bittencourt, PI; Gutierrez, LL; Maslinkiewicz, A | 1 |
8 other study(ies) available for cyclopentane and Atherosclerosis
| Article | Year |
|---|---|
A novel nitroalkene-α-tocopherol analogue inhibits inflammation and ameliorates atherosclerosis in Apo E knockout mice.
Topics: alpha-Tocopherol; Animals; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Cyclopentanes; Cytokines; Female; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Molecular Structure; Nitro Compounds; RAW 264.7 Cells | 2019 |
G protein-coupled estrogen receptor protects from atherosclerosis.
Topics: Animals; Atherosclerosis; Cholesterol, LDL; Cyclopentanes; Endothelial Cells; Female; Humans; Intracellular Membranes; Mice; Mice, Knockout; Nitric Oxide; Postmenopause; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled | 2014 |
NEDDylation promotes endothelial dysfunction: a role for HDAC2.
Topics: Animals; Aorta; Arginase; Atherosclerosis; Cell Line; Cyclopentanes; Endopeptidases; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Histone Deacetylase 2; Humans; Lipoproteins, LDL; Mice; NEDD8 Protein; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Proteolysis; Pyrimidines; Signal Transduction; Tissue Culture Techniques; Ubiquitination; Ubiquitins | 2015 |
A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Carotid Arteries; CHO Cells; Cricetulus; Cyclopentanes; Diet, Atherogenic; Disease Models, Animal; Isoquinolines; Male; Mice; Monocytes; Receptors, CCR2 | 2017 |
High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx.
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cholesterol, HDL; Cyclopentanes; Diabetes Mellitus, Experimental; Glucose; Hyperglycemia; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Scavenger Receptors, Class B; Thiosemicarbazones | 2010 |
EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes.
Topics: Animals; Apoptosis; Atherosclerosis; Caspase 3; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclopentanes; Diabetes Mellitus, Type 2; Disease Models, Animal; Furans; Ginkgo biloba; Ginkgolides; Humans; Immunoblotting; Kaempferols; Male; Muscle, Smooth, Vascular; Plant Extracts; Quercetin; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; Tunica Intima; U937 Cells | 2011 |
LipoCardium: endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions.
Topics: Animals; Atherosclerosis; Cyclopentanes; Disease Models, Animal; Feasibility Studies; Lipid Metabolism; Liposomes; Macrophages; Male; Mice; Prostaglandins; Prostaglandins A; Rats; Rats, Wistar | 2007 |
Atherosclerosis: a redox-sensitive lipid imbalance suppressible by cyclopentenone prostaglandins.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Cholesterol; Cyclopentanes; Humans; Ligands; Lipid Metabolism; Macrophages; Oxidation-Reduction; Prostaglandins; Protein Binding | 2008 |